Anabolic/Ergogenic Research Group (AERG)

Printer-friendly versionPrinter-friendly version
About: 

The AERG is one of a handful of American research groups conducting research on use practices, motivations, consequences and complications of steroidal and nonsteroidal anabolic and ergo/thermogenic drugs – Appearance- and Performance-Enhancing Drugs, or APEDs – by elite athletes and instrumental users. The AERG has published several instruments for the study of these issues, including the sole reliable and valid diagnostic instrument for (the APEDUS).  The AERG and possesses and is continuing to collect the largest and most complex internet-gathered samples of users to date.

Research Aim(s): 
  • Publishing results of ergo/thermogenic use in the V1.0 internet sample of APED users.
  • Building a V2.0 internet sample of APED users using an APEDUS-derived survey instrument
  • Developing the concept of the Androgen Intoxication Syndrome and its implications for emerging social problems, including excess police violence caused by APED-using officers.
Recent Press and Presentations: 

Sanjuan, P., Langenbucher, J., & Hildebrandt, T. (in press).  Mood symptoms in steroid users: The unexamined role of concurrent stimulant use.  Journal of Substance Use.

San Juan, P., Langenbucher, J., & Pearson, M. (in press).  Conditional effects of appearance and performance enhancing drug (APED) use on mood in powerlifters and bodybuilders.  Alcoholism Treatment Quarterly.

Hildebrandt, T., Langenbucher, J., Harty, S., Flores, A., & Berlin, H. (2014). The influence of age of onset and acute anabolic steroid exposure on cognitive performance, impulsivity, and aggression in men.  Psychology of Addictive Behaviors, 2014;  [Epub May 19, 2014]

Hildebrandt, T., Harty, S., & Langenbucher, J.W. (2012).  Fitness supplements as a gateway substance for anabolic-androgenic steroid use.  Psychology of Addictive Behaviors, 26(4), 955-956.

Pandina, R., Langenbucher, J.W., & Hildebrandt, T. (2012).  Designer drugs, hallucinogens, and anabolic steroids.  In B. S McCrady & E. E. Epstein (Eds.),  Addiction: A Comprehensive Handbook, 2nd Edition, pp. 456-468.  New York: Guilford Press.

Hildebrandt, T., Lai, J.K., Langenbucher, J.W., Shneider, M., Pfaff, D., & Yehuda, R. (2011).  The diagnostic dilemma of appearance and performance enhancing drug misuse.  Drug and Alcohol Dependence, 114(1), 1-11.

Hildebrandt, T., Langenbucher, J., Lai, J., Loeb, K., & Hollander, E. (2011).  Development and validation of the Appearance and Performance Enhancing Drug Use Schedule. Addiction, 36(10), 949-958.

Hildebrandt, T., Alfano, L., & Langenbucher, J. (2010).  Body image disturbance in 1000 male appearance- and performance-enhancing drug users.  Journal of Psychiatric Research 44 (13), 841-846.

Personnel: 
Core Faculty: James Langenbucher
Affiliated Faculty: Thomas Hildebrant, Mt. Sinai School of Medicine
Pilar San Juan, University of New Mexico
Will Folberth, Long Island Jewish Hospital